Headache

Article	Citations
Issue Information	396
Virtual issue: Kids (with headache disorders) are not just little adults (with headache disorders)	67
Issue Information	58
Longitudinal assessment of comorbidities and co‐occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)	55
RETRACTION: Effectiveness of anti‐CGRP monoclonal antibodies for persistent headaches in patients with idiopathic intracranial hypertension	55
Issue Information	53
	50
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	48
Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine	46
Not their fault: Mental health characteristics of parents with migraine and the migraine status of their children	46
Developing multivariable models for predicting headache improvement in patients with acute post‐traumatic headache attributed to mild traumatic brain injury: A preliminary study	45
Headache activity associated with the 2024 North American eclipse	45
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study	44
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene‐related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patien	40
	35
Early effect of onabotulinumtoxinA on EEG‐based functional connectivity in patients with chronic migraine: A pilot study	34
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	33
Thank you to Dr. Dana Turner	33
Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine	29
Reversible cerebral vasoconstriction syndrome after levonorgestrel‐releasing intrauterine device placement—Case report	29
Heavy metal and trace element alterations in patients during a migraine attack	29
Erenumab patient characteristics, medication adherence, and treatment patterns in the United States	29
Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study	29
Trainee highlights	28
A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and li	28

	28
Post‐traumatic headache: An unmet medical need	28
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study	27
Refractory glossopharyngeal neuralgia successfully treated with onabotulinumtoxinA: A case report	26
Visual temporal discrimination is impaired in patients with migraine without aura	26
Intranasal treatment of cluster headache	24
Issue Information	24
Migraine and peripheral pain models show differential alterations in neuronal complexity	24
Continuous updating of individual headache forecasting models using Bayesian methods	24
Trainee highlights	23
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	23
Lifetime history of an anxiety or depression disorder and adherence to medications used for the acute treatment of migraine	23
	23
Issue Information	21
Author Index	21
Functional magnetic resonance imaging of headache: Issues, best‐practices, and new directions, a narrative review	20
Could osmophobia be a clinical diagnostic marker for migraine?	20
Current practice for primary headache disorders and perspectives on peripheral nerve blocks among emergency physicians in Canada: A national survey	19
Developing an artificial intelligence–based diagnostic model of headaches from a dataset of clinic patients' records	19
Treatment of hemiplegic migraine with anti‐calcitonin gene‐related peptide monoclonal antibodies: A case series in a tertiary‐care headache center	19
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	18
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	18
Comparison of migraine with left‐ versus right‐sided headache: A cross‐sectional study	18
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	17
Reliability, validity, and responsiveness of the Arabic version of HIT‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study	17
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	17
Prevalence and burden of migraine in the United States: A systematic review	17
Clinical pattern and response to treatment of primary stabbing headache: Retrospective case series study from a Portuguese tertiary hospital	17
Effects of caffeine on intracranial pressure and pain perception in freely moving rats	16
The value of the patient perspective in understanding the full burden of migraine	16
Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials	16
Impact of the COVID‐19 pandemic on people living with migraine: Results of the MiCOAS qualitative study	16
Issue Information	16
Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes	15
	15
Computed tomography‐guided radiofrequency ablation of cervical intervertebral discs for the treatment of refractory cervicogenic headache: A retrospective chart review	15
Migraine and large artery atherosclerosis in young adults with ischemic stroke	15
Did she have an epidural? The long‐term consequences of postdural puncture headache and the role of unintended dural puncture	15
Do behavioral treatments work for migraine prevention?	15
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	15
Headache response after CT‐guided fibrin glue occlusion of CSF‐venous fistulas	15
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	15
Familial hemiplegic migraine in pediatric patients: A genetic, clinical, and follow‐up study	15
Sensory hypersensitivities are associated with post‐traumatic headache‐related disability	15
Localization in headache medicine: A systematic approach to diagnosis	14
Narrative review of migraine management in patients with renal or hepatic disease	14
Treatment of chronic migraine with medication overuse: A perspective	14
Vitamin D concentrations in patients with cluster headache: A matched case–control study	14
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	14
Treatment of multiple sclerosis–related trigeminal neuralgia with onabotulinumtoxinA	14

The 2023 Scottsdale Headache Symposium	14
Patient headache questionnaires can improve headache diagnosis and treatment in children	14
Neuralgia in the occipital region associated with ipsilateral trigeminal herpes zoster: Three case reports	13
Ahead of the pain: Where we stand after a decade of growth in United Council for Neurologic Subspecialties‐certified headache subspecialists	13
Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience	13
Beyond myths: Transformative insights into spinal cerebrospinal fluid leaks and their role in persistent headache syndromes	13
Issue Information	13
Celebrating Headache's 2023 graduating class of Assistant Editors	13
Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study	13
Migraine treatment with external concurrent occipital and trigeminal neurostimulation—A randomized controlled trial	13
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	13
Hemicrania continua secondary to pituitary macroadenoma responsive to nerve blocks: A case report	13
The importance of patient and family perspectives of clinical decisions in pediatric headache	12
Migraine in women	12
Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios	12
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes	12
Transient side shift of cluster headache attacks after unilateral greater occipital nerve injection	12
Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study	12
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group	12
Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review	12
Migraine screening in English and Spanish	12
Off‐label use of lacosamide, an alternative for the treatment of neuropathic pain	12
Physical activity pattern and migraine according to aura symptoms in the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil) cohort: A cross‐sectional study	12
Real‐world approaches to outpatient treatment of status migrainosus: A survey study	12
Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine	12
Eptinezumab improved patient‐reported outcomes in patients with migraine and medication‐overuse headache: Subgroup analysis of the randomized PROMISE‐2 trial	12
Symptomatic visual snow in acute ischemic stroke: A case series	11
Use of combined hormonal contraception and stroke: A case‐control study of the impact of migraine type and estrogen dose on ischemic stroke risk	11
Aura is a symptom of a migraine attack, not its cause	11
Characteristics of acute ischemic stroke and unusual aura in patients with migraine with aura	11
Beyond pain control: Outcome and treatment preferences in pediatric migraine	11
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	11
Narrative review of peripheral nerve blocks for the management of headache	11
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	11
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	10
Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study	10
The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: A systematic review and network analysis	10
Basic Science Prize Award 2023	10
The 2024 Scottsdale Headache Symposium: A banner year	10
Issue Information	10
Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study	10
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	10
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	9
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	9
Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain	9
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	9
Association of periodontal disease with migraine: A large‐scale community‐based cross‐sectional study	9
Erratum	9
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	9
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	9
Understanding the gaps in headache and migraine treatment with psychological and behavioral interventions: A narrative review	9
Normal glymphatic system function in patients with migraine: A pilot study	9
Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review	9
A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management	9
Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage	9
Factors to predict recurrence after epidural blood patch in patients with spontaneous intracranial hypotension	9
Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active‐duty service members and veterans	9
Role of memantine in the prophylactic treatment of episodic migraine: A systematic review	9
Association between secondhand smoke exposure and severe headaches or migraine in never‐smoking adults	9
To test or not to test? Do red flags play any role?	8
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	8
Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine	8
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	8
Visual inspection versus spectrophotometry for xanthochromia detection in patients with sudden onset severe headache—A diagnostic accuracy study	8
	8
Erratum	8
Predictors of migraine interictal burden: The hidden role of subjective memory complaints	8
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	8
Healthcare resource use and costs associated with the misdiagnosis of migraine	8
Headache: Reflections on 2021 and looking forward to 2022	8
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	8
Assessing attack‐related fear in headache disorders—Structure and psychometric properties of the Fear of Attacks in Migraine Inventory	8
Issue Information	8
Artificial intelligence terminology, methodology, and critical appraisal: A primer for headache clinicians and researchers	8
Author Index	7
Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
Issue Information	7
Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group	7
Issue Information	7
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study	7

Diagnosing new daily persistent headache in children and adolescents: A survey of clinicians	7
Effect of prednisolone for the treatment of medication‐overuse headache: A 3‐month result from a multicenter REgistry for Load and management of mEdicAtion overuSE headache (RELEASE) study	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Information theory and headache triggers	7
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	7
Indomethacin‐responsive headaches—A narrative review	7
Issue Information	7
	7
Neuromodulation for primary headache disorders: Advantages and challenges	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
The teaching of headache medicine in France: A questionnaire‐based study	7
	6
Low pulse pressure and high serum complement C1q are risk factors for hemodialysis headache: A case–control study	6
Altered resting‐state effective connectivity of trigeminal vascular system in migraine without aura: A spectral dynamic causal modeling study	6
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	6
Reduction in retinal microvascular perfusion during migraine attacks	6
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion	6
Erratum	6
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	6
Intranasal treatment of cluster headache: A response	6
Medication overuse headache in patients with chronic migraine using cannabis: A case–referent study	6
Grand rounds education in neurology, with a focus on headache medicine	6
Headache fellowship match shareholder insights	6
Shaping a new era of medicine at the American Headache Society Annual Scientific Meeting	6
The effect of the COVID‐19 pandemic on headache‐related disability among young adults with migraine	6
Bone site fracture pain after subcutaneous sumatriptan injection: A report of two cases	6
Autophagy may protect the brain against prolonged consequences of headache attacks: A narrative/hypothesis review	6
Headache rounds: Postural headache in a patient with squamous cell carcinoma	6
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	6
Issue Information	6
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial	6
Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”	6
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid	6
Aryl hydrocarbon receptors improve migraine‐like pain behaviors in rats through the regulation of regulatory T cell/T‐helper 17 cell‐related homeostasis	6
Author Index	5
Postural orthostatic tachycardia syndrome and migraine: A narrative review	5
Memantine for migraine—Big promise but little evidence	5
Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative	5
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID‐19 pandemic: Lessons from a tertiary headache center in Mila	5
Issue Information	5
Rising migraine incidence in adolescents despite stable prevalence in the US: A call for further investigation	5
Understanding the links between airborne hazards and headache disorders	5
Hypermobility spectrum disorders and active migraine in Israeli adolescents: A nationwide study	5
Headache attributed to airplane travel: Time for a multicentric international survey?	5
Frequency of headache in emergency department patients with anaphylaxis: A cross‐sectional study	5
Comparing treatments in the emergency department: What works for migraine?	5
	5
	5
Characterization of rimegepant drug–drug interactions using the cytochrome P450 probe drugs, itraconazole, rifampin, fluconazole, and midazolam	5
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	5
Fremanezumab plus plasmapheresis in a patient with chronic migraine and myasthenia gravis: Case report of an effective treatment	5
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	5
	5
Structural aberrations of the brain associated with migraine: A narrative review	5
Crystal‐clear days and unclear days in migraine: A population‐based study	5
Common challenges in the development of prediction models	5
Most bothersome symptoms in patients with migraine: A hospital‐based study in Taiwan	5
Visual aura without headache as a pre‐cluster symptom in episodic cluster headache: A report of two cases	5
Trainee highlights	5
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	5
Headache basic science prize	5
Ultrasound‐guided stellate ganglion block for the treatment of migraine in elderly patients: A retrospective and observational study	5
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	5
A qualitative study on the long‐term effectiveness of occipital nerve stimulation in patients with chronic cluster headache	5
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	5
Popping the balloon	5
Trainee highlights	5